Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Metzger

Showing results (31-40 of 61) with videos related to

Pageof 7
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2007
A Myc-Groucho complex integrates EGF and Notch signaling to regulate neural developmentAmir Orian, Jeffrey J Delrow, Alicia E Rosales Nieves, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|May 20, 2009
Relationships between social norms, social network characteristics, and HIV risk behaviors in Thailand and the United StatesCarl Latkin, Deborah Donnell, David D Celentano, et al.
The International Journal on Drug Policy|August 20, 2011
Short-term safety of buprenorphine/naloxone in HIV-seronegative opioid-dependent Chinese and Thai drug injectors enrolled in HIV Prevention Trials Network 058Gregory M Lucas, Geetha Beauchamp, Apinun Aramrattana, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 29, 2019
Using Interrupted Time Series Analysis to Measure the Impact of Legalized Syringe Exchange on HIV Diagnoses in Baltimore and PhiladelphiaMonica S Ruiz, Allison OʼRourke, Sean T Allen, et al.
Biological Psychiatry|October 20, 2007
Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndromeDwight L Evans, Kevin G Lynch, Tami Benton, et al.
AIDS and Behavior|October 24, 2012
Recruitment of urban US women at risk for HIV infection and willingness to participate in future HIV vaccine trialsBarbara Metch, Ian Frank, Richard Novak, et al.
AIDS (London, England)|October 18, 2005
Effect of GB virus C viremia on HIV acquisition and HIV set-pointGregory P Bisson, Brian L Strom, Robert Gross, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 23, 2014
HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trialGeorge E Woody, Douglas Bruce, P Todd Korthuis, et al.
AIDS and Behavior|August 30, 2020
Mental Health, Social Influences, and HIV Pre-exposure Prophylaxis (PrEP) Utilization Among Men and Transgender Individuals Screening for HIV Prevention TrialsSarah M Wood, Knashawn H Morales, David Metzger, et al.
Social Science & Medicine (1982)|December 17, 2008
The efficacy of a network intervention to reduce HIV risk behaviors among drug users and risk partners in Chiang Mai, Thailand and Philadelphia, USACarl A Latkin, Deborah Donnell, David Metzger, et al.
Pageof 7

Showing results (31-40 of 61) with videos related to

Sort By:
Pageof 7
Proceedings of the National Academy of Sciences of the United States of America|September 28, 2007
A Myc-Groucho complex integrates EGF and Notch signaling to regulate neural developmentAmir Orian, Jeffrey J Delrow, Alicia E Rosales Nieves, et al.
Health Psychology : Official Journal of the Division of Health Psychology, American Psychological Association|May 20, 2009
Relationships between social norms, social network characteristics, and HIV risk behaviors in Thailand and the United StatesCarl Latkin, Deborah Donnell, David D Celentano, et al.
The International Journal on Drug Policy|August 20, 2011
Short-term safety of buprenorphine/naloxone in HIV-seronegative opioid-dependent Chinese and Thai drug injectors enrolled in HIV Prevention Trials Network 058Gregory M Lucas, Geetha Beauchamp, Apinun Aramrattana, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|October 29, 2019
Using Interrupted Time Series Analysis to Measure the Impact of Legalized Syringe Exchange on HIV Diagnoses in Baltimore and PhiladelphiaMonica S Ruiz, Allison OʼRourke, Sean T Allen, et al.
Biological Psychiatry|October 20, 2007
Selective serotonin reuptake inhibitor and substance P antagonist enhancement of natural killer cell innate immunity in human immunodeficiency virus/acquired immunodeficiency syndromeDwight L Evans, Kevin G Lynch, Tami Benton, et al.
AIDS and Behavior|October 24, 2012
Recruitment of urban US women at risk for HIV infection and willingness to participate in future HIV vaccine trialsBarbara Metch, Ian Frank, Richard Novak, et al.
AIDS (London, England)|October 18, 2005
Effect of GB virus C viremia on HIV acquisition and HIV set-pointGregory P Bisson, Brian L Strom, Robert Gross, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 23, 2014
HIV risk reduction with buprenorphine-naloxone or methadone: findings from a randomized trialGeorge E Woody, Douglas Bruce, P Todd Korthuis, et al.
AIDS and Behavior|August 30, 2020
Mental Health, Social Influences, and HIV Pre-exposure Prophylaxis (PrEP) Utilization Among Men and Transgender Individuals Screening for HIV Prevention TrialsSarah M Wood, Knashawn H Morales, David Metzger, et al.
Social Science & Medicine (1982)|December 17, 2008
The efficacy of a network intervention to reduce HIV risk behaviors among drug users and risk partners in Chiang Mai, Thailand and Philadelphia, USACarl A Latkin, Deborah Donnell, David Metzger, et al.
Pageof 7